SCHEMBL2067871

SCHEMBL2067871

CC(C)NC(=O)c1ccn[c]c1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.46
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
GAA P10253 2/20 0.36
ALDH1A1 P00352 4/20 0.36
HTT P42858 2/20 0.36
USP2 O75604 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
KDM4E B2RXH2 3/20 0.36
MLYCD O95822 1/20 0.35
GLA P06280 1/20 0.35
PKM P14618 1/20 0.35
PDE4A P27815 1/20 0.34
KCNH2 Q12809 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
CASP1 P29466 1/20 0.34
CHRM2 P08172 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3513476 0.88 ALOX5 (0.36) ALOX5MAOAMAOBGAAALDH1A1
SCHEMBL2067727 0.81 GAA (0.38) GAAALDH1A1ADRA1DADRA1AADRA1B
SCHEMBL27090280 0.78 KDM4E (0.53) GAAALDH1A1KDM4EGLAALOX15
SCHEMBL2068758 0.77 CHIA (0.38) GAAALDH1A1HTTADRA1DADRA1A
SCHEMBL2067879 0.77 ALOX5 (0.40) ALOX5MAOAMAOBALDH1A1KDM4E
SCHEMBL2069207 0.72 SMN1; SMN2 (0.50) GAAALDH1A1PKMALOX15
SCHEMBL11538360 0.69 PRKCI (0.58) ALOX5ALDH1A1KDM4EPDE4AKCNH2
SCHEMBL6281925 0.68 CES1 (0.34) ALDH1A1HTTKDM4E
SCHEMBL9210426 0.68 TDP1 (0.53) ALOX5MAOAMAOBGAAALDH1A1
SCHEMBL9215519 0.68 TDP1 (0.53) ALOX5MAOAMAOBGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140005163-A1 1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES NOVARTIS AG (CH) 2014-01-02 US disclosed
US-8476294-B2 1H-imidazo[4,5-c]quinolinone derivatives NOVARTIS AG (CH) 2013-07-02 US disclosed
EP-2438064-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES Novartis AG (CH) 2012-04-11 EP disclosed
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES NOVARTIS AG 2010-12-16 US disclosed
WO-2010139731-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES NOVARTIS AG (CH) 2010-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES PRKCA, CSNK1A1, ABL1 ALOX5 3509/4885MAOA 4181/4885MAOB 4602/4885
US-20140005163-A1 1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES PRKCA, CSNK1A1, ABL1 ALOX5 3509/4885MAOA 4181/4885MAOB 4602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.